Glenview Capital has reduced its holdings in CVS Health by 3.75 million shares following strong Q1 results and raised annual guidance, after the stock gained 80% since their initial investment in May 2024. Despite the reduction, CVS remains one of Glenview's three largest positions, reflecting confidence in the company's ongoing operational turnaround and long-term growth prospects. The fund plans no further adjustments, citing CVS's efforts to improve pharmacy services, medication access, and healthcare navigation as key factors supporting its positive outlook.
CVS Health has invested $9 million in the development of The Mews at St. Mary, a new 75-unit affordable senior housing complex in Williamstown, New Jersey. This project, in partnership with the Diocesan Housing Services Corporation, The Walters Group...
CVS Health has announced a renewed commitment to support military-connected individuals and families through a comprehensive approach that includes healthcare access, community programs, and economic opportunities. Partnering with organizations like ...
EnsembleIQ’s DSN has launched the #FillHealthCareGaps campaign to support community pharmacies as America faces a shortage of 80,000 primary care physicians by 2030. The campaign includes a website, video, and LinkedIn initiative showcasing pharmacis...
The Vanguard Short-Term Corporate Bond Index ETF (VCSH) yields about 4.42%, significantly higher than typical 1-year CDs which offer around 1.5%-2.0%, with top CDs reaching 4.0%. While CDs provide FDIC insurance and guaranteed income, VCSH carries ri...
A CVS Health white paper reveals that 58% of older Americans feel low digital health literacy negatively impacts their health management, with 85% struggling to navigate digital health tools. Despite these challenges, 86% are open to using digital he...
